Gelonghui, March 27 | Xintong Medical-B (02160.HK) announced that for the year ended December 31, 2023, revenue was approximately RMB 336 million, up 33.9% year on year; gross profit was approximately RMB 230 million, up 41.8% year on year; loss attributable to the company's equity shareholders was approximately RMB 472 million; loss attributable to the company's equity shareholders was approximately RMB 454 million; basic loss per share.
心通医疗-B(02160.HK)：2023年收入3.36亿元 同比增加33.9%
Xintong Medical-B (02160.HK): Revenue of 336 million yuan in 2023 increased by 33.9% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.